The Memo: Nia Therapeutics Unlocking the Brain’s Potential to Restore Memory

Under the direction of Co-Founders Dan Rizzuto, President & Chief Technical Officer, and Mike Kahana, Chief Executive Officer, Nia Therapeutics is developing cutting-edge neurostimulation technology to restore memory function. The company’s innovation targets memory loss resulting from TBI, neurodegenerative diseases, and other conditions, aiming to improve patients’ quality of life and redefine the treatment landscape. This blog is originally published here: https://www.lifesciencemarketr....esearch.com/insights

The Weekly Recap 11/1/24: LSI Alumni Achievements Driving Medtech and Healthtech Forward

In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni raise substantial new funding, receive Breakthrough Device Designation, appoint new executives, and much more on the road to LSI USA ‘25 in Dana Point, CA (March 17-21). For more information visit https://www.lifesciencemarketr....esearch.com/insights

Keynote with the CEO of Edwards Lifesciences and Managing Partner & COO of SV Health Investors

This keynote, moderated by Paul LaViolette of SV Health Investors, goes into depth with new Edwards Lifesciences CEO, Bernard Zovighian. We learn about Bernard's journey, his vision, and some life lessons along the way. For more details visit

Incubating Medtech Companies and Improving Stroke Outcomes, with Trendlines Investments and Ceretrieve

The discussion delves into the dynamic landscape of medical device innovation, with a particular focus on Trendlines' funding strategy and its transformative partnership with Ceretrieve. Barak outlines Trendlines' investment philosophy, which entails identifying unmet needs, supporting early-stage companies, and nurturing them from ideation to expansion. Maysa narrates her journey from academia to entrepreneurship, unveiling the remarkable story of Ceretrieve's development.